BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19473199)

  • 1. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection.
    Choudhry N; Korbel DS; Edwards LA; Bajaj-Elliott M; McDonald V
    Cell Microbiol; 2009 Sep; 11(9):1354-64. PubMed ID: 19473199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
    Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
    J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma-mediated activation of enterocytes in immunological control of Encephalitozoon intestinalis infection.
    Choudhry N; Korbel DS; Zaalouk TK; Blanshard C; Bajaj-Elliott M; McDonald V
    Parasite Immunol; 2009 Jan; 31(1):2-9. PubMed ID: 19121078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
    Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
    Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum.
    Pollok RC; Farthing MJ; Bajaj-Elliott M; Sanderson IR; McDonald V
    Gastroenterology; 2001 Jan; 120(1):99-107. PubMed ID: 11208718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.
    Ehigiator HN; McNair N; Mead JR
    Exp Parasitol; 2007 Feb; 115(2):107-13. PubMed ID: 16920103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells.
    Choudhry N; Petry F; van Rooijen N; McDonald V
    J Infect Dis; 2012 Jul; 206(1):117-24. PubMed ID: 22517912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
    Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
    J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
    Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
    Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
    Jakobi V; Petry F
    Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
    Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
    J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction.
    Lean IS; McDonald SA; Bajaj-Elliott M; Pollok RC; Farthing MJ; McDonald V
    Infect Immun; 2003 Aug; 71(8):4580-5. PubMed ID: 12874337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.
    Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Lahoti S; White AC
    Cytokine; 2001 Jul; 15(1):39-46. PubMed ID: 11509007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.
    Ehigiator HN; Romagnoli P; Borgelt K; Fernandez M; McNair N; Secor WE; Mead JR
    Parasite Immunol; 2005; 27(1-2):17-28. PubMed ID: 15813719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptosporidium parvum: the course of Cryptosporidium parvum infection in C57BL/6 mice co-infected with the nematode Heligmosomoides bakeri.
    Bednarska M; Bajer A; Sinski E
    Exp Parasitol; 2008 Sep; 120(1):21-8. PubMed ID: 18522859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
    Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
    Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.
    Rogers KA; Rogers AB; Leav BA; Sanchez A; Vannier E; Uematsu S; Akira S; Golenbock D; Ward HD
    Infect Immun; 2006 Jan; 74(1):549-56. PubMed ID: 16369011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidiosis induces a transient upregulation of the oligopeptides transporter (PepT1) activity in neonatal rats.
    Marquet P; Barbot L; Planté A; Huneau JF; Gobert JG; Kapel N
    Exp Biol Med (Maywood); 2007 Mar; 232(3):454-60. PubMed ID: 17327480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice.
    Stephens J; Cosyns M; Jones M; Hayward A
    Hepatology; 1999 Jul; 30(1):27-35. PubMed ID: 10385635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.
    White AC; Robinson P; Okhuysen PC; Lewis DE; Shahab I; Lahoti S; DuPont HL; Chappell CL
    J Infect Dis; 2000 Feb; 181(2):701-9. PubMed ID: 10669358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.